| Flora Yan, MD | |
|
1440 Mount Vernon St Apt 413, Philadelphia, PA 19130-3474 | |
| (972) 363-3864 | |
| Not Available |
| Full Name | Flora Yan |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Location | 1440 Mount Vernon St Apt 413, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144890328 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MT223277 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Flora Yan, MD 1440 Mount Vernon St Apt 413, Philadelphia, PA 19130-3474 Ph: (972) 363-3864 | Flora Yan, MD 1440 Mount Vernon St Apt 413, Philadelphia, PA 19130-3474 Ph: (972) 363-3864 |
News Archive
A study of nearly 4000 pairs of mothers and their children in the Children of the 90s study at the University of Bristol has shown that maternal vitamin D levels during pregnancy are not associated with the child's bone health in later life. The research, published Online First in The Lancet, is the largest ever observational study of the effects of mothers' vitamin D levels in pregnancy on their children's bone health, and suggests that UK health guidelines may be overstating the importance of vitamin D supplementation in pregnancy.
Poor-quality sleep marked by frequent awakenings can speed cancer growth, increase tumor aggressiveness and dampen the immune system's ability to control or eradicate early cancers, according to a new study published online January 21, 2014, in the journal Cancer Research.
Investigators in The Research Institute at Nationwide Children's Hospital have identified the role of a protein that could potentially lead to new clinical treatments to combat musculoskeletal diseases, including Duchenne muscular dystrophy (DMD).
QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer's disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
A team of scientists from Imperial College London has conducted a series of in vitro studies to investigate the susceptibility of endothelial cells to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the causative pathogen of coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
Mark Rizzi, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104 Phone: 215-590-3440 Fax: 215-590-3986 | |
Rebecca Claire Chiffer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St Fl 6, Philadelphia, PA 19107 Phone: 215-955-6760 | |
Lukas David Dumberger, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-662-4613 | |
Dr. Marc R. Rosen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St, 6th Floor, Philadelphia, PA 19107 Phone: 215-955-6760 Fax: 215-923-4532 | |
Dr. Robert T Adelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 | |
Steven Bernard Cannady, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-829-5180 | |
Alexander G Chiu, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-614-0071 |